97精品国产自-97精品国产自产-97精品国产综合久久-97精品久-97精品免费视频-97精品人人

廚房設備網
手機版
首頁> 資訊>政策法規> 正文

(EU) No 2015/1492:就乙酰異戊酰泰樂菌素,修訂法規(EU) No 37/2010附錄

發布時間:2017-05-02 09:35:41   發布人: 互聯網    點擊數:566  

COMMISSION IMPLEMENTING REGULATION (EU) 2015/1492     of 3 September 2015     amending Regulation (EU) No 37/2010 as regards the substance ‘tylvalosin’     (Text with EEA relevance)     THE EUROPEAN COMMISSION,     Having regard to the Treaty on the Functioning of the European Union,     Having regard to Regulation (EC) No 470/2009 of the European Parliament and of the Council of 6 May 2009 laying down Community procedures for the establishment of residue limits of pharmacologically active substances in foodstuffs of animal origin, repealing Council Regulation (EEC) No 2377/90 and amending Directive 2001/82/EC of the European Parliament and of the Council and Regulation (EC) No 726/2004 of the European Parliament and of the Council (1), and in particular Article 14 in conjunction with Article 17 thereof,     Having regard to the opinion of the European Medicines Agency formulated by the Committee for Medicinal Products for Veterinary Use,     Whereas:     (1)     Article 17 of Regulation (EC) No 470/2009 requires that the maximum residue limit (hereinafter ‘MRL’) for pharmacologically active substances intended for use in the Union in veterinary medicinal products for food-producing animals or in biocidal products used in animal husbandry is established in a regulation.     (2)     Table 1 of the Annex to Commission Regulation (EU) No 37/2010 (2) sets out the pharmacologically active substances and their classification regarding MRLs in foodstuffs of animal origin.     (3)     Tylvalosin is currently included in that table as an allowed substance, for porcine and poultry species, applicable to muscle, skin and fat, liver and kidney in porcine species and to skin and fat and liver in poultry species, excluding animals producing eggs for human consumption.     (4)     An application for the extension of the existing entry for tylvalosin to chicken eggs has been submitted to the European Medicines Agency (hereinafter ‘EMA’).     (5)     The EMA, based on the opinion of the Committee for Medicinal Products for Veterinary Use has recommended the establishment of a MRL for chicken eggs.     (6)     According to Article 5 of Regulation (EC) No 470/2009 the EMA is to consider using MRLs established for a pharmacologically active substance in a particular foodstuff for another foodstuff derived from the same species, or MRLs established for a pharmacologically active substance in one or more species for other species.     (7)     The EMA has considered that the extrapolation of the MRLs for tylvalosin from chicken eggs to eggs of other poultry species is appropriate.     (8)     Regulation (EU) No 37/2010 should therefore be amended accordingly.     (9)     It is appropriate to grant the stakeholders concerned a reasonable period of time to take measures that may be required to comply with the new MRL.     (10)     The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products,     HAS ADOPTED THIS REGULATION:     Article 1     The Annex to Regulation (EU) No 37/2010 is amended as set out in the Annex to this Regulation.     Article 2     This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.     It shall apply from 3 November 2015.     This Regulation shall be binding in its entirety and directly applicable in all Member States.     Done at Brussels, 3 September 2015.     For the Commission     The President     Jean-Claude JUNCKER     (1)  OJ L 152, 16.6.2009, p. 11.     (2)  Commission Regulation (EU) No 37/2010 of 22 December 2009 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin (OJ L 15, 20.1.2010, p. 1).     ANNEX     In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry for the substance ‘tylvalosin‘ is replaced by the following:
   

harmacologically active substance

Marker residue

Animal species

MRL

Target tissues

Other provisions (according to Article 14(7) of Regulation (EC) No 470/2009)

Therapeutic classification

‘Tylvalosin

Tylvalosin

orcine

50 μg/kg

50 μg/kg

50 μg/kg

50 μg/kg

Muscle

kin and fat

Liver

Kidney

O ENTRY

Anti-infectious agents/Antibiotics’

oultry

200 μg/kg

Eggs

um of Tylvalosin and 3-0-acetyltylosin

oultry

50 μg/kg

50 μg/kg

kin and fat

Liver

免責聲明:本網站所收集的部分公開資料來源于互聯網,轉載的目的在于傳遞更多信息及用于網絡分享,并不代表本站贊同其觀點和對 其真實性負責,也不構成任何其他建議。如果您發現網站上有侵犯您的知識產權的作品,請與我們取得聯系,我們會及時修改或刪除。

同類資訊

推薦資訊 更多
點擊排行

版權所有:廚聯科技 (c)2008-2022 CFSBCN All Rights Reserved

客戶服務郵箱:350319542@cfsbcn.com 郵編:610000 蜀ICP備14006818號-4 聯系電話:13880215230

成都地址:成都高新區府城大道西段399天府新谷10號樓17F

主站蜘蛛池模板: 99久久精品国产精油按摩店 | 99国产精品丝袜久久久久 | 波多野结衣一区二区三区四区欧美剧高清在线观看 | 国产成人亚洲综合无码加勒比一 | 精品亚洲?ⅴ无码午夜在线 精品亚洲a∨无码一区二区三区 | 亚洲天堂日韩欧美在线 | 国产精品久久久无码A片小说 | 精品国产国偷自产在线观看99久久久无码国产精品免费精品乱 | 韩国理伦片一区二区三区在线播放 | 免费看片亚洲 | 久久99AV无色码人妻蜜柚 | 久久AV无码乱码A片无码蜜桃 | 欧美a级毛欧美1级a大片式放 | 日韩在线免费观看av网站 | 本一道色欲综合网中文字幕 | 成人免费无码动漫h在线观看 | 91国内免费久久久久久久久久 | 99精品国产色综合久久不卡 | 无码人妻精品一区二区三区性色 | 国产精品熟女四五十路一区二区 | 色欲AV亚洲一区无码少妇 | 成人国产一区二区三区精品不 | 欧美亚洲日本在线观看 | 日产亚洲一区二区三区 | 久久久久亚洲Av片无码一区 | 国产三级电影在线观看一区二区三区 | 宅男午夜成年影视在线观看 | 国产极品白嫩精品无码视频 | 国产va免费精品高清在线 | 五月天高清无码一区 | 成人免费无毒在线观看网站 | 日韩人妻鲁交色情精品视频 | 色中色成人论坛 | 亚洲第一区二区快射影院 | 精品久久久久水蜜桃一二三 | 国产成人精品第一区 | 在线观看国产剧情麻豆精品 | 成人午夜精品一级毛片 | 97无码人妻福利免费公开在 | 91精品啪在 | 日本国产美国日韩欧美mv |